Meet our panel of medical specialists

Dr Malinda Itchins BMedSc; MBBS (Hons1), FRACP and PhD Candidate, Bill Walsh Translational Cancer Research Laboratory, Kolling Institute. Malinda is a PhD candidate through the University of Sydney investigating mechanisms of resistance to tyrosine kinase inhibitors in ALK-rearranged non-small cell lung cancer. She is a practicing Medical Oncologist at Northern Cancer Institute, St Leonards and North Shore Private Hospital. Malinda completed her Medical Oncology Training at Royal North Shore Hospital in 2016 and is an active member of the Australasian Lung Cancer Trials Group (ALTG)... read more »

Associate Professor Nick Pavlakis, BSc MBBS MMed (Clin. Epi) PhD FRACP), who is an academic medical oncologist and Senior Staff Specialist in Medical Oncology at Sydney’s Royal North Shore Hospital. He is the current President of the Australasian Lung Cancer Trials Group (ALTG), current President of the Clinical Oncology Society of Australia (COSA) and Regent for Australasia for the International Association for the Study of Lung Cancer. His clinical interests are in lung cancer and mesothelioma, and gastrointestinal cancers. He is involved in ongoing collaborative clinical research and translational research focusing on drug development and biomarkers... read more »

Dr Csilla Hasovits (BSc (Med) MBBS (Hons 1) FRACP) graduated from the University of New South Wales in 2004 and undertook her postgraduate training at Royal North Shore Hospital. She obtained her Fellowship in Medical Oncology in 2012. Csilla is currently undertaking a PhD through the University of Sydney at the Bill Walsh Translational Cancer Research Laboratory in her area of interest in lung cancer, evaluating treatment resistance according to EGFR mutation status... read more »